Real-World

Evidence & Economics

Evidence - Peer Review Published Study

  • The study in the Journal of Infusion Nursing conducted at Wake Forest University School of Medicine found:
  • Six out of eight errors occurred in low-light conditions, which are common in ICU conditions. MedLite ID has zero errors in low-light conditions.
  • 24% percent faster in accessing the primary medication line injection port
  • 40% less mental tasking as quantified within the study. 
MedLite-ID_iStock-1133574865

Evidence - Patient Trial, 500 Bed Veteran Affair Hospital 

  • CCU, MICU, SICU / 1 month baseline data, 3 months product trial data

  • Standard of Care (Tape/Labels): 19-58 seconds, time to access primary medication line port

  • MedLite ID: 1-7 seconds, time to access primary medication line port

  • 271%+ improvement from MedLite ID  

Time to Access Port Results Graph

Evidence - Intermountain Healthcare 

  • 83% of nurses recommended the adoption of MedLite ID.

  • 78% of nurses reported increased overall patient safety and care.

  • 81% of nurses noticed improved efficiency associated with line tracing.

  • 87% of nurses claimed reduced stress associated with line tracing.

Evidence - Utah Tech 

  • 100% decreased the time it took them to find the medication line with an overall time savings of 34%, or nearly one minute.

  • 100% expressed how the MedLite ID reduced their stress levels.

  • Average time savings per trial was 57.3 seconds with just 4 lines.

  • 51% nursing productivity/ efficiency improvement.

Evidence - MedLite Tape Study

Icon-IV-line

  • 80% of the used rolls tested positive for pathogens.

  • 16 of the 36 bacteria and fungi found were pathogenic.

  • Two bacteria identified as critical or serious by the World Health Organization.

MedLite Evidence Summary

What Can MedLite Smart Lites Do For You?

  • 78% Increase in Patient Safety
  • 34% Reduction in Time to Identify
  • 81% Improved Efficency
  • 87% Nurse Stress Reduction
  • 200% reduction in time to access port

83% Nurse Adoption

Request a Trial

Best Practices for multiple IV co-administration infusions.

From AHRQ: An Inadvertent Bolus of Norepinephrine. Administration of multiple IV infusions is ubiquitous in the ICU, and there are several established safety parameters associated with medication concentration, dosing, and pump programming. The physical dexterity required for administering multiple IV infusions concurrently is underappreciated, and lack thereof can, in fact, lead to serious harm.  AHRQ addressed this issue in a recent article, including recognizing risks associated with medication administration, the most frequent types of IV medical errors in the ICU, and best practices for the co-administration of multiple IV infusions. (Reprinted with permission.)

Eligible for

MedLite ID - Line Identification to prevent ADEs
Eliminate workplace stress with Medlite ID

MedLite ID & Infectious Disease

Reduce exposure to infectious disease by up to two hours per day per 12-hour shift.   Not marketing math, simple math...

  • Healthcare workers can be exposed more often due to numerous infected individuals. Reducing the frequency and intensity of exposure to infectious diseases list MRSA or SARs-CoV-2 might reduce the infectious dose and result in less severe cases.

  • Icon-Covid-Checklist

    MedLite ID takes a minutes procedure and turns it into seconds to identify and trace key infusion lines.  Doing that every 1-2 hours for multiple patients adds up.  The ability to identify key infusion lines and reduce exposure protects both the patient and nurse alike.  MedLite can also be used with extension tubing to further reduce exposure.

     

$250K Per Year To the Bottom Line

Adding MedLite ID converts a daily loss to a daily savings

  • 56% of ADEs are Infusion Related
  • 19 ADEs per 1000 ICU Patient Days
  • 17+ Drugs Per Day in ICU
  • $6600 Average ADE Costs Per Event
  • 15% of Infusion ADE = Wrong Route Errors
  • Cost/day of $2883 of each unplanned inpatient day
  • Average medical malpractice claim $242K
  • 2% risk of Mortality from ADE

For Every 100 Beds of Hospital

Request a Trial

Economics 

What is the cost of doing nothing?  At even a smaller, 200-bed hospital, we can convert an estimated $620,000 annual loss in direct costs from infusion ADE to $490,000 per year in savings after paying for the MedLite ID solution.  That does not factor in the significant liability avoidance from medical practice or wrongful death, with a solution that can be deployed in less than 1/2 a day.  

  • Based on literature rates of infusion ADE, a 100-bed hospital is projected to be at-risk for 22  infusion ADEs annually.
  • This is an annual loss of $310K in direct costs from infusion ADE- a loss that can be avoided.
  • After paying for MedLite ID, a net $245K in savings is possible.

Possible IV ADE Loss Per 100 Beds

153-IV-ADE-Possible

Possible Savings Per
100 Beds

553k-YearSavings